Skip to main content

Diagnostic options Β· UAE

Biochemistry tests in Dubai & UAE

Compare available Biochemistry tests, their listed prices and the information provided for each option. Test selection and preparation should be discussed with your clinician.

Tests in this category

1,113

Listed price range

450.00–30,000.00 AED

Clinical preparation

Confirm test-specific instructions with your clinician or laboratory.

Compare available tests

Biochemistry test prices

Showing 436–450 of 1,113 matching tests.

Biochemistry diagnostic tests, details, and listed prices
Test and description Specimen Typical duration Price Options
TEST-2571
GFM2 Gene Microcephaly with Simplified Gyral Pattern and Insulin‑Dependent Diabetes Genetic Test

This genetic test identifies pathogenic variants in the GFM2 gene associated with microcephaly with simplified gyral pattern and insulin-dependent diabetes.

Whole Blood (EDTA) or FTA Card (DNA) 3–4 Weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["Pathogenic variants in the GFM2 gene"]
Parameters
[]
Preparation
["No specific fasting required", "Avoid sample contamination"]
Indications
["Suspected GFM2-related syndrome", "Microcephaly with simplified gyral pattern", "Early-onset insulin-dependent diabetes"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 82939-0 ICD-10: Q02, E10.9, Z15.89
Clinical summary
This genetic test identifies pathogenic variants in the GFM2 gene associated with microcephaly with simplified gyral pattern and insulin-dependent diabetes.
TEST-2811
GHR Gene Analysis (Growth Hormone Insensitivity, Partial) Test

This test evaluates the GHR gene for pathogenic variants associated with partial growth hormone insensitivity (Laron syndrome). It helps identify the genetic cause of the condition...

Peripheral whole blood (3–5 mL in EDTA tube) or FTA card 3 to 4 weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["GHR gene sequence variants", "Copy Number Variations (CNV) in GHR gene"]
Parameters
[]
Preparation
["No specific fasting required", "Inform phlebotomist of any medications"]
Indications
["Children with unexplained short stature", "Delayed growth", "Family history of Laron syndrome", "Evaluation of growth failure despite normal GH levels"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 21662-6 ICD-10: E34.3, E23.0
Clinical summary
This test evaluates the GHR gene for pathogenic variants associated with partial growth hormone insensitivity (Laron syndrome). It helps identify the genetic cause of the condition.
TEST-3785
GHRHR Gene Growth Hormone Deficiency Genetic Test

This test detects pathogenic variants in the GHRHR gene associated with isolated growth hormone deficiency type IB.

Peripheral Whole Blood (EDTA), Extracted DNA, or FTA Card 3–4 Weeks from sample receipt in laboratory 2,800.00 AED
View
View test specifications and preparation
What it measures
["Pathogenic variants in GHRHR gene", "Single-nucleotide variants", "Small insertions and deletions", "Copy-number alterations"]
Parameters
[]
Preparation
[]
Indications
["Diagnosis of isolated growth hormone deficiency type IB", "Guiding targeted endocrine therapy", "Informed family planning"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 81343-6 ICD-10: E23.0
Clinical summary
This test detects pathogenic variants in the GHRHR gene associated with isolated growth hormone deficiency type IB.
TEST-5610
GJB2 Gene (KID Syndrome) Genetic Test

This test evaluates the GJB2 gene for pathogenic variants associated with Keratitis-Ichthyosis-Deafness (KID) syndrome.

Whole Blood (EDTA), Extracted DNA (β‰₯1 Β΅g), or Dried Blood Spot (FTA Card) 3–4 Weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["GJB2 gene coding region", "GJB2 gene splice sites"]
Parameters
[]
Preparation
[]
Indications
["Suspected KID syndrome based on clinical presentation", "Family history of KID syndrome"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 21629-6 ICD-10: Q80.8
Clinical summary
This test evaluates the GJB2 gene for pathogenic variants associated with Keratitis-Ichthyosis-Deafness (KID) syndrome.
TEST-5552
GJB2 Gene Keratoderma, Palmoplantar, with Deafness Genetic Test

This test evaluates the GJB2 gene for pathogenic variants associated with Palmoplantar Keratoderma with Deafness (PPK-D). It identifies mutations causing a syndromic combination of...

Peripheral whole blood (3–5 mL in EDTA tube) or extracted DNA 3–4 Weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["Pathogenic variants in the GJB2 gene (Connexin 26)", "Full coding region sequencing", "Deep read depth analysis"]
Parameters
[]
Preparation
["No specific dietary or medication restrictions are required.", "Continue all prescribed medications unless advised otherwise by a specialist.", "Inform the phlebotomist of any anticoagulant therapy."]
Indications
["Individuals with clinical features suggestive of PPK-D", "Family history of PPK-D", "Genetic counseling for individuals at risk"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 21657-2 ICD-10: Q82.8, H90.5
Clinical summary
This test evaluates the GJB2 gene for pathogenic variants associated with Palmoplantar Keratoderma with Deafness (PPK-D). It identifies mutations causing a syndromic combination of thickened palms/soles and sensorineural hearing loss.
TEST-5756
GJB3 Gene Deafness (DFNA2B) Genetic Test

This test evaluates the GJB3 gene for pathogenic variants associated with autosomal dominant non-syndromic hearing loss (DFNA2B) and keratoderma-deafness syndromes.

Peripheral whole blood (EDTA), dried blood spot (FTA card), or previously extracted genomic DNA 3–4 Weeks from sample receipt 2,800.00 AED
View
View test specifications and preparation
What it measures
["GJB3 gene sequence", "Single nucleotide variants (SNVs)", "Copy number variations (CNVs)"]
Parameters
[]
Preparation
["No fasting required", "No specific medication or diet restrictions"]
Indications
["Diagnosis of autosomal dominant non-syndromic hearing loss (DFNA2B)", "Diagnosis of keratoderma-deafness syndromes", "Genetic counselling for families with GJB3-related hearing loss"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 21636-6 ICD-10: H90.3
Clinical summary
This test evaluates the GJB3 gene for pathogenic variants associated with autosomal dominant non-syndromic hearing loss (DFNA2B) and keratoderma-deafness syndromes.
TEST-5123
GJB3 Gene Erythrokeratodermia Variabilis et Progressiva Genetic Test

This test identifies pathogenic variants in the GJB3 gene associated with Erythrokeratodermia Variabilis et Progressiva (EKVP).

Whole blood (EDTA), extracted DNA, or dried blood spot on FTA card 21–28 calendar days from sample receipt 2,800.00 AED
View
View test specifications and preparation
What it measures
["GJB3 gene coding region", "GJB3 gene splice-site coverage"]
Parameters
[]
Preparation
["Mandatory pre-test genetic counselling session.", "Provide previous genetic testing reports and complete family history."]
Indications
["Suspected Erythrokeratodermia Variabilis et Progressiva (EKVP)", "Family cascade screening for EKVP"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 95209-3 ICD-10: Q80.8
Clinical summary
This test identifies pathogenic variants in the GJB3 gene associated with Erythrokeratodermia Variabilis et Progressiva (EKVP).
TEST-6356
GK Gene Glycerol Kinase Deficiency Genetic Test

This test identifies pathogenic variants in the GK gene, confirming a molecular diagnosis of glycerol kinase deficiency.

Peripheral Whole Blood (3–5 mL EDTA), or Buccal Swab, or FTA Card, or Extracted DNA 3 to 4 Weeks (21–28 days) 2,800.00 AED
View
View test specifications and preparation
What it measures
["Pathogenic variants in the GK gene", "Single nucleotide variants", "Small insertions/deletions", "Copy number variations (CNVs)"]
Parameters
[]
Preparation
["Mandatory pre-test genetic counselling session required", "No fasting required", "Consent verification during home visit"]
Indications
["Suspected glycerol kinase deficiency", "Family history of glycerol kinase deficiency", "Need for definitive molecular diagnosis", "Guiding family screening and future pregnancies"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 81321-1 ICD-10: E74.8
Clinical summary
This test identifies pathogenic variants in the GK gene, confirming a molecular diagnosis of glycerol kinase deficiency.
TEST-4013
GLA Gene Fabry Disease Genetic Test

This test evaluates the GLA gene for mutations associated with Fabry disease using Next-Generation Sequencing (NGS) with Copy Number Variation (CNV) detection.

Whole blood (EDTA), Extracted DNA, or FTA Card 3–4 weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["Alpha-galactosidase A (GLA) gene sequence", "Copy number variations (CNVs) in the GLA gene"]
Parameters
[]
Preparation
[]
Indications
["Suspected Fabry disease based on clinical symptoms", "Family history of Fabry disease", "Carrier screening in at-risk females", "Confirmation of borderline enzyme results"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 21687-4 ICD-10: E75.21, Z15.89, Z84.89
Clinical summary
This test evaluates the GLA gene for mutations associated with Fabry disease using Next-Generation Sequencing (NGS) with Copy Number Variation (CNV) detection.
TEST-4556
GLB1 Gene GM1-Gangliosidosis Genetic Test

This genetic test identifies pathogenic variants in the GLB1 gene associated with GM1-gangliosidosis.

Blood, Extracted DNA, or FTA DNA Card 3–4 Weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["Pathogenic variants in the GLB1 gene", "Point mutations", "Copy number variants (CNVs)"]
Parameters
[]
Preparation
["No special preparation required", "Genetic counselling session recommended before sample collection"]
Indications
["Diagnosis of GM1-gangliosidosis", "Carrier screening for GM1-gangliosidosis", "Personalized management of GM1-gangliosidosis"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 81313-7 ICD-10: E75.0
Clinical summary
This genetic test identifies pathogenic variants in the GLB1 gene associated with GM1-gangliosidosis.
TEST-6256
GLB1 Gene GM1-Gangliosidosis Type 2 Genetic Test

This genetic test identifies pathogenic variants in the GLB1 gene associated with GM1-gangliosidosis type 2, a rare autosomal recessive lysosomal storage disorder.

Whole Blood (EDTA, 3–5 mL), Extracted DNA (minimum 2 Β΅g), or FTA Card 3 to 4 Weeks from sample receipt 2,800.00 AED
View
View test specifications and preparation
What it measures
["Pathogenic variants in the GLB1 gene", "Copy Number Variations (CNV) in GLB1"]
Parameters
[]
Preparation
["No fasting required", "Mandatory pre-test genetic counselling session"]
Indications
["Suspected GM1-gangliosidosis type 2", "Family history of lysosomal storage disorders", "Carrier status clarification"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 101655-8 ICD-10: E75.19, Z14.8, Z13.79
Clinical summary
This genetic test identifies pathogenic variants in the GLB1 gene associated with GM1-gangliosidosis type 2, a rare autosomal recessive lysosomal storage disorder.
TEST-3793
GLDC Gene Glycine Encephalopathy Genetic Test

This test identifies pathogenic variants in the GLDC gene, which are responsible for causing glycine encephalopathy (nonketotic hyperglycinemia). It is a targeted next-generation s...

Whole blood (EDTA) or buccal swab 21 working days 2,800.00 AED
View
View test specifications and preparation
What it measures
["Pathogenic variants in GLDC gene coding regions", "Single nucleotide variants (SNVs)", "Small insertions and deletions (indels)"]
Parameters
[]
Preparation
["No specific fasting required", "No medication or diet restrictions"]
Indications
["Clinical suspicion of nonketotic hyperglycinemia", "Family history of glycine encephalopathy", "Abnormal newborn screening results", "Need for definitive molecular diagnosis"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 83084-7 ICD-10: E72.21
Clinical summary
This test identifies pathogenic variants in the GLDC gene, which are responsible for causing glycine encephalopathy (nonketotic hyperglycinemia). It is a targeted next-generation sequencing assay.
TEST-2449
GLI3 Gene Pallister-Hall Syndrome Genetic Test

This test identifies pathogenic variants in the GLI3 gene associated with Pallister-Hall syndrome.

Whole Blood, Extracted DNA, or Dried Blood Spot 3–4 Weeks (21–28 business days) 2,800.00 AED
View
View test specifications and preparation
What it measures
["Pathogenic variants in the GLI3 gene", "Likely pathogenic variants in the GLI3 gene"]
Parameters
[]
Preparation
["No fasting or special dietary preparation required", "Pre-test genetic counseling session mandatory", "Clinical history form completion by referring physician", "Legal guardian consent mandatory for minors"]
Indications
["Clinical suspicion of Pallister-Hall syndrome", "Documented family history of GLI3-related disorders"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 82939-0 ICD-10: Q87.8
Clinical summary
This test identifies pathogenic variants in the GLI3 gene associated with Pallister-Hall syndrome.
TEST-4535
GLRA1 Gene Hyperekplexia Genetic Test

This test analyzes the GLRA1 gene for mutations associated with hereditary hyperekplexia, also known as startle disease.

Peripheral whole blood (EDTA tube) 3–4 weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["GLRA1 gene coding regions", "GLRA1 gene splice sites", "Copy number variants in GLRA1"]
Parameters
[]
Preparation
["Mandatory genetic counselling session with pedigree chart documentation", "Clinical history of the proband and affected relatives must be provided"]
Indications
["Clinical suspicion of hyperekplexia", "Family history of hyperekplexia", "Reproductive risk assessment for hyperekplexia"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 78948-8 ICD-10: G25.8
Clinical summary
This test analyzes the GLRA1 gene for mutations associated with hereditary hyperekplexia, also known as startle disease.
TEST-1363
Glucagon Plasma Test

This test measures the level of glucagon in the plasma to aid in the diagnosis and management of conditions related to glucagon secretion and metabolism.

Plasma (EDTA) 2–3 Weeks (batch-based) 1,800.00 AED
View
View test specifications and preparation
What it measures
["Fasting plasma glucagon levels"]
Parameters
[{"name": "Glucagon", "reference_range": null}]
Preparation
["Overnight fasting (8–12 hours)", "Inform physician of all current medications, especially GLP-1 receptor agonists"]
Indications
["Evaluation of hypoglycemia", "Diabetes management", "Investigation of pancreatic neuroendocrine tumors (glucagonoma, alpha-cell disorders)"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 4235-2 ICD-10: E16.3
Clinical summary
This test measures the level of glucagon in the plasma to aid in the diagnosis and management of conditions related to glucagon secretion and metabolism.

Category overview

Biochemistry: overview

Seeking clarity about your body's essential functions is vital for long-term well-being. At DNA Labs UAE, our Biochemistry services utilize advanced automated analyzers to evaluate enzymes, proteins, and metabolites in your blood. Whether you need routine metabolic panels or specialized biochemical testing in the UAE, these tests provide critical data to guide your physician's medical plan. As a leading diagnostic lab in Dubai and the UAE, we guarantee strict confidentiality and rapid, accurate turnaround times. Take charge of your health today. Explore our biochemistry diagnostics below, schedule a convenient home sample collection, or contact our specialists to book your test.

Before booking

Use the test details as a conversation starter

The right diagnostic option depends on your reason for testing and individual circumstances. Check the listed specimen and timing, then confirm any preparation requirements with the ordering clinician or laboratory before collection.

Explore this area